High materiality8/10
RBC Capital Starts Guardant Health (GH) at Outperform, 'Underpenetrated Market'
Why it may matterVerify against the original reporting
Upside supported by addressable market.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital starts GH at Outperform; target $185; current price $130.9; underpenetrated market.
- RBC Capital starts GH at Outperform; target $185; current price $130.9; underpenetrated market.
Key facts
- 01
Target: $185
- 02
Posted price: $130.9
- 03
Analyst firm: RBC Capital
- 04
Analyst: Dan Leonard
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.